Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 1
1986 1
1987 3
1988 1
1989 2
1990 1
1991 2
1992 2
1993 1
1994 5
1996 5
1999 5
2000 2
2001 4
2002 1
2003 4
2004 4
2005 3
2006 10
2007 5
2008 11
2009 10
2010 4
2011 6
2012 8
2013 9
2014 7
2015 7
2016 6
2017 3
2018 6
2019 5
2020 4
2021 4
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Learning lessons.
Holmgren CJ, Monse B, van Palenstein HW, Benzian H. Holmgren CJ, et al. Br Dent J. 2011 Apr 9;210(7):292-3. doi: 10.1038/sj.bdj.2011.248. Br Dent J. 2011. PMID: 21475260 No abstract available.
Uterine rupture associated with VBAC.
Holmgren CM. Holmgren CM. Clin Obstet Gynecol. 2012 Dec;55(4):978-87. doi: 10.1097/GRF.0b013e31826fd9b0. Clin Obstet Gynecol. 2012. PMID: 23090467 Review.
A popular misconception.
Holmgren C, Frencken J. Holmgren C, et al. Br Dent J. 2005 Nov 12;199(9):587. doi: 10.1038/sj.bdj.4812923. Br Dent J. 2005. PMID: 16288261 No abstract available.
New uses for ancient middens: bridging ecological and evolutionary perspectives.
Becklin KM, Betancourt JL, Braasch J, Dézerald O, Díaz FP, González AL, Harbert R, Holmgren CA, Hornsby AD, Latorre C, Matocq MD, Smith FA. Becklin KM, et al. Among authors: holmgren ca. Trends Ecol Evol. 2024 May;39(5):479-493. doi: 10.1016/j.tree.2023.12.003. Epub 2024 Mar 28. Trends Ecol Evol. 2024. PMID: 38553315 Review.
154 results